[1]
|
Weaver, F.M., Follett, K., Stern, M., Hur, K., Harris, C., Marks Jr., W.J., et al. (2009) Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: A randomized controlled trial. JAMA, 301, 63-73. doi:10.1001/jama.2008.929
|
[2]
|
Williams, A., Gill, S., Varma, T., Jenkinson, C., Quinn, N., Mitchell, R., et al. (2010) Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson’s disease (PD SURG trial): A randomised, open-label trial. The Lancet Neurology, 9, 581-591. doi:10.1016/S1474-4422(10)70093-4
|
[3]
|
Parsons, T.D., Rogers, S.A., Braaten, A.J., Woods, S.P. and Tr?ster, A.I. (2006) Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson’s disease: A meta-analysis. The Lancet Neurology, 5, 578-588.
doi:10.1016/S1474-4422(06)70475-6
|
[4]
|
Voon, V., Kubu, C., Krack, P., Houeto, J.L. and Tr?ster, A.I. (2006) Deep brain stimulation: Neuropsychological and neuropsychiatric issues. Movement Disorders, 21, S305-S327. doi:10.1002/mds.20963
|
[5]
|
Witt, K., Daniels, C., Reiff, J., Krack, P., Volkmann, J., Pinsker, M.O., et al. (2008) Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson’s disease: A randomised, multicentre study. The Lancet Neurology, 7, 605-614.
doi:10.1016/S1474-4422(08)70114-5
|
[6]
|
Stuss, D.T. and Levine, B. (2002) Adult clinical neuropsychology: Lessons from studies of the frontal lobes. Annual Review of Psychology, 53, 401-433.
doi:10.1146/annurev.psych.53.100901.135220
|
[7]
|
Lezak, M.D., Howieson, D.B. and Loring, D.W. (2004) Neuropsychological assessment. 4th Edition, Oxford University Press, New York.
|
[8]
|
Zangaglia, R., Pacchetti, C., Pasotti, C., Mancini, F., Servello, D., Sinforiani, E., et al. (2009) Deep brain stimulation and cognitive functions in Parkinson’s disease: A three-year controlled study. Movement Disorders, 24, 1621-1628. doi:10.1002/mds.22603
|
[9]
|
Auclair-Ouellet, N., Chantal, S., Cantin, L., Prud’homme, M., Langlois, M. and Macoir, J. (2011) Transient executive dysfunction following STN-DBS in Parkinson’s disease. Canadian Journal of Neurological Sciences, 38, 360-363.
|
[10]
|
Yamanaka, T., Ishii, F., Umemura, A., Miyata, M., Horiba, M., Oka, Y., et al. (2012) Temporary deterioration of executive function after subthalamic deep brain stimulation in Parkinson’s disease. Clinical Neurology and Neurosurgery, 114, 347-351.
doi:10.1016/j.clineuro.2011.11.009
|
[11]
|
Schüpbach, M., Gargiulo, M., Welter, M.L., Mallet, L., Béhar, C., Houeto, J.L., et al. (2006) Neurosurgery in Parkinson disease: A distressed mind in a repaired body? Neurology, 66, 1811-1816.
doi:10.1212/01.wnl.0000234880.51322.16
|
[12]
|
Smeding, H.M., Speelman, J.D., Koning-Haanstra, M., Schuurman, P.R., Nijssen, P., van Laar, T., et al. (2006) Neuropsychological effects of bilateral STN stimulation in Parkinson disease: A controlled study. Neurology, 66, 1830-1836. doi:10.1212/01.wnl.0000234881.77830.66
|
[13]
|
Tomlinson, C.L., Stowe, R., Patel, S., Rick, C., Gray, R. and Clarke, C.E. (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Movement Disorders, 25, 2649-2653.
doi:10.1002/mds.23429
|
[14]
|
Perriol, M.P., Krystkowiak, P., Defebvre, L., Blond, S., Destée, A. and Dujardin, K. (2006) Stimulation of the subthalamic nucleus in Parkinson’s disease: Cognitive and affective changes are not linked to the motor outcome. Parkinsonism & Related Disorders, 12, 205-210.
doi:10.1016/j.parkreldis.2005.11.009
|
[15]
|
Benarroch, E.E. (2008) Subthalamic nucleus and its connections: Anatomic substrate for the network effects of deep brain stimulation. Neurology, 70, 1991-1995.
doi:10.1212/01.wnl.0000313022.39329.65
|
[16]
|
Baláz, M., Rektor, I. and Pulkrábek, J. (2008) Participation of the subthalamic nucleus in executive functions: An intracerebral recording study. Movement Disorders, 23, 553-557. doi:10.1002/mds.21873
|
[17]
|
Cools, R., Stefanova, E., Barker, R.A., Robbins, T.W. and Owen, A.M. (2002) Dopaminergic modulation of highlevel cognition in Parkinson’s disease: The role of the prefrontal cortex revealed by PET. Brain, 125, 584-594.
doi:10.1093/brain/awf052
|
[18]
|
Funkiewiez, A., Ardouin, C., Krack, P., Fraix, V., Van Blercom, N., Xie, J., et al. (2003) Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson’s disease. Movement Disorders, 18, 524-530. doi:10.1002/mds.10441
|
[19]
|
Dujardin, K., Sockeel, P., Delliaux, M., Destée, A. and Defebvre, L. (2009) Apathy may herald cognitive decline and dementia in Parkinson’s disease. 24, 2391-2397.
doi:10.1002/mds.22843
|
[20]
|
Butterfield, L.C., Cimino, C.R., Oelke, L.E., Hauser, R.A. and Sanchez-Ramos, J. (2010) The independent influence of apathy and depression on cognitive functioning in Parkinson’s disease. Neuropsychology, 24, 721-730.
doi:10.1037/a0019650
|
[21]
|
Smeding, H.M., Speelman, J.D., Huizenga, H.M., Schuurman, P.R. and Schmand B. (2011) Predictors of cognitive and psychosocial outcome after STN DBS in Parkinson’s disease. Journal of Neurology, Neurosurgery & Psychiatry, 82, 754-760.
doi:10.1136/jnnp.2007.140012
|
[22]
|
Daniels, C., Krack, P., Volkmann, J., Pinsker, M.O., Krause, M., Tronnier, V., et al. (2010) Risk factors for executive dysfunction after subthalamic nucleus stimulation in Parkinson’s disease. Movement Disorders, 25, 1583-1589. doi:10.1002/mds.23078
|
[23]
|
Lang, A.E., Houeto, J.L., Krack, P., Kubu, C., Lyons, K.E., Moro, E., et al. (2006) Deep brain stimulation: Preoperative issues. Movement Disorders, 21, S171-196.
doi:10.1002/mds.20955
|
[24]
|
Starkstein, S.E., Preziosi, T.J., Berthier, M.L., Bolduc, P.L., Mayberg, H.S., Robinson, R.G. (1989) Depression and cognitive impairment in Parkinson’s disease. Brain, 112, 1141-1153. doi:10.1093/brain/112.5.1141
|
[25]
|
Giladi, N., Treves, T.A., Paleacu, D., Shabtai, H., Orlov, Y., Kandinov, B., et al. (2000) Risk factors for dementia, depression and psychosis in long-standing Parkinson’s disease. Journal of Neural Transmission, 107, 59-71.
doi:10.1007/s007020050005
|
[26]
|
Mayberg, H.S., Starkstein, S.E., Sadzot, B., Preziosi, T., Andrezejewski, P.L., Dannals, R.F., et al. (1990) Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson’s disease. Annals of Neurology, 28, 57-64. doi:10.1002/ana.410280111
|
[27]
|
Mayberg, H.S. (1994) Frontal lobe dysfunction in secondary depression. The Journal of Neuropsychiatry and Clinical Neurosciences, 6, 428-442.
|
[28]
|
Smeding, H.M., van den Munckhof, P., Esselink, R.A., Schmand, B., Schuurman, P.R. and Speelman, J.D. (2007) Reversible cognitive decline after DBS STN in PD and displacement of electrodes. Neurology, 68, 1235-1236.
doi:10.1212/01.wnl.0000259067.68691.87
|
[29]
|
Tsai, S.T., Lin, S.H., Lin, S.Z., Chen, J.Y., Lee, C.W. and Chen, S.Y. (2007) Neuropsychological effects after chronic subthalamic stimulation and the topography of the nucleus in Parkinson’s disease. Neurosurgery, 61, E1024-E1029. doi:10.1227/01.neu.0000303198.95296.6f
|
[30]
|
York, M.K., Wilde, E.A., Simpson, R. and Jankovic, J. (2009) Relationship between neuropsychological outcome and DBS surgical trajectory and electrode location. Journal of the Neurological Sciences, 287, 159-171.
doi:10.1016/j.jns.2009.08.003
|